Investors Financial Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Investors Financial Group’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,439	Closed	-$9K	–	148
2019 Q4	$9K	Buy	+16,439	New	+$39.9K	0.01%	134

Investors Financial Group's MLNT Position: Q1 2020 in Review

Investors Financial Group sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 16,439 shares — an estimated $9K sold.

Investors Financial Group first reported a position in MLNT in Q4 2019 and held it in 1 quarter. The position peaked at $9K in Q4 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Investors Financial Group reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Investors Financial Group sold 16,439 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $9K.
Investors Financial Group first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
Investors Financial Group's Melinta Therapeutics, Inc. Common Stock position peaked at $9K in Q4 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Investors Financial Group's 13F filing for Q1 2020, filed 9 Apr 2020.